These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31049833)
1. Contribution of aorta glycosaminoglycans and PCSK9 to hyperlipidemia in experimental rabbits: the role of 10-dehdrogingerdione as effective modulator. Elseweidy MM; Elswefy SE; Younis NN; Tarek S Mol Biol Rep; 2019 Aug; 46(4):3921-3928. PubMed ID: 31049833 [TBL] [Abstract][Full Text] [Related]
2. The modulation of PCSK-9 and GAGs by 10-dehydrogingerdione and pentoxifylline in hyperlipidemic rabbits. Elseweidy MM; Elswefy SE; Younis NN; Tarek S Nat Prod Res; 2020 Aug; 34(16):2372-2377. PubMed ID: 30580599 [TBL] [Abstract][Full Text] [Related]
3. Potential therapeutic roles of 10-dehydrogingerdione and/or pentoxifylline against calcium deposition in aortic tissues of high dietary cholesterol-fed rabbits. Elseweidy MM; Mohamed HE; Elrashidy RA; Atteia HH; Elnagar GM; Ali AE Mol Cell Biochem; 2019 Mar; 453(1-2):131-142. PubMed ID: 30173373 [TBL] [Abstract][Full Text] [Related]
4. Dyslipidemia induced inflammatory status, platelet activation and endothelial dysfunction in rabbits: Protective role of 10-Dehydrogingerdione. El-Seweidy MM; Sarhan Amin R; Husseini Atteia H; El-Zeiky RR; Al-Gabri NA Biomed Pharmacother; 2019 Feb; 110():456-464. PubMed ID: 30530048 [TBL] [Abstract][Full Text] [Related]
5. Haemostatic risk factors in dyslipidemic rabbits: role of 10-dehydrogingerdione as a new hypolipemic agent. El-Seweidy MM; Asker Mel-S; Eldahmy SI; Atteia HH; Abdallah MA J Thromb Thrombolysis; 2015 Feb; 39(2):196-202. PubMed ID: 25388083 [TBL] [Abstract][Full Text] [Related]
6. Synergistic Cardioprotective Effects of Combined Chromium Picolinate and Atorvastatin Treatment in Triton X-100-Induced Hyperlipidemia in Rats: Impact on Some Biochemical Markers. Shafik NM; Baalash A; Ebeid AM Biol Trace Elem Res; 2017 Dec; 180(2):255-264. PubMed ID: 28409410 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Aortic Calcification by Policosanol in Dyslipidemic Rabbits Is Enhanced by Pentoxifylline: Potential Role of PCSK9. Elseweidy MM; Mohamed HE; Elrashidy RA; Atteia HH; Elnagar GM J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):551-560. PubMed ID: 29742924 [TBL] [Abstract][Full Text] [Related]
8. Mice Fed a High-Cholesterol Diet Supplemented with Quercetin-3-Glucoside Show Attenuated Hyperlipidemia and Hyperinsulinemia Associated with Differential Regulation of PCSK9 and LDLR in their Liver and Pancreas. Mbikay M; Mayne J; Sirois F; Fedoryak O; Raymond A; Noad J; Chrétien M Mol Nutr Food Res; 2018 May; 62(9):e1700729. PubMed ID: 29396908 [TBL] [Abstract][Full Text] [Related]
9. Potential role of lycopene in targeting proprotein convertase subtilisin/kexin type-9 to combat hypercholesterolemia. Sultan Alvi S; Ansari IA; Khan I; Iqbal J; Khan MS Free Radic Biol Med; 2017 Jul; 108():394-403. PubMed ID: 28412198 [TBL] [Abstract][Full Text] [Related]
10. 10-Dehydrogingerdione raises HDL-cholesterol through a CETP inhibition and wards off oxidation and inflammation in dyslipidemic rabbits. Elseweidy MM; Abdallah FR; Younis NN; Aldohmy S; Kassem HM Atherosclerosis; 2013 Dec; 231(2):334-40. PubMed ID: 24267247 [TBL] [Abstract][Full Text] [Related]
12. Hypolipidemic effect of fenugreek seeds and its comparison with atorvastatin on experimentally induced hyperlipidemia. Sharma MS; Choudhary PR J Coll Physicians Surg Pak; 2014 Aug; 24(8):539-42. PubMed ID: 25149829 [TBL] [Abstract][Full Text] [Related]
13. [Effect of NIP-200 on hyperlipidemia and atherosclerosis in cholesterol-fed rabbits]. Sakamoto K; Yamauchi M; Nakayama S; Tsuruzoe N; Sakashita M; Fujikawa Y Nihon Yakurigaku Zasshi; 1987 Oct; 90(4):187-93. PubMed ID: 3428776 [TBL] [Abstract][Full Text] [Related]
14. Early myocardial injury biomarkers in diabetic hyperlipidemic rats: Impact of 10-dehydrogingerdione and vitamin D3. Elseweidy MM; Aly SI; Hammad SK; Shershir NI Exp Biol Med (Maywood); 2020 Sep; 245(15):1326-1334. PubMed ID: 32686474 [TBL] [Abstract][Full Text] [Related]
15. New Insight on a Combination of Policosanol and 10-Dehydrogingerdione Phytochemicals as Inhibitors for Platelet Activation Biomarkers and Atherogenicity Risk in Dyslipidemic Rabbits: Role of CETP and PCSK9 Inhibition. Elseweidy MM; Amin RS; Atteia HH; El-Zeiky RR; Al-Gabri NA Appl Biochem Biotechnol; 2018 Dec; 186(4):805-815. PubMed ID: 29740798 [TBL] [Abstract][Full Text] [Related]
16. Attenuation of oxidative stress, inflammation, and endothelial dysfunction in hypercholesterolemic rabbits by allicin. El-Sheakh AR; Ghoneim HA; Suddek GM; Ammar ESM Can J Physiol Pharmacol; 2016 Feb; 94(2):216-224. PubMed ID: 26618400 [TBL] [Abstract][Full Text] [Related]
17. Anti-tumor necrosis factor-α therapy increases plaque burden in a mouse model of experimental atherosclerosis. Oberoi R; Vlacil AK; Schuett J; Schösser F; Schuett H; Tietge UJF; Schieffer B; Grote K Atherosclerosis; 2018 Oct; 277():80-89. PubMed ID: 30176568 [TBL] [Abstract][Full Text] [Related]
18. NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. Momi S; Impagnatiello F; Guzzetta M; Caracchini R; Guglielmini G; Olivieri R; Monopoli A; Gresele P Eur J Pharmacol; 2007 Sep; 570(1-3):115-24. PubMed ID: 17632098 [TBL] [Abstract][Full Text] [Related]
19. Ginkgolide B Mediated Alleviation of Inflammatory Cascades and Altered Lipid Metabolism in HUVECs via Targeting PCSK-9 Expression and Functionality. Wang G; Liu Z; Li M; Li Y; Alvi SS; Ansari IA; Khan MS Biomed Res Int; 2019; 2019():7284767. PubMed ID: 31281844 [TBL] [Abstract][Full Text] [Related]
20. A Comparative Study of Lipid-Lowering Effects of Guggul and Atorvastatin Monotherapy in Comparison to Their Combination in High Cholesterol Diet-Induced Hyperlipidemia in Rabbits. Das S; Datta A; Bagchi C; Chakraborty S; Mitra A; Tripathi SK J Diet Suppl; 2016; 13(5):495-504. PubMed ID: 26735695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]